Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Northwestern University
Northwestern University
Stanford University
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Swiss Cancer Institute